Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment

NCT04868253 is registered in ClinicalTrials.gov with Rose Research Center, LLC as lead sponsor.

NCT NCT04868253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04868253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
Lead sponsor
Rose Research Center, LLC
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 19, 2021
Completion date
December 31, 2021
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation, tobacco use disorder